Translational research & Preclinical

Rheomuco: A solution tailored to your needs

Translational research and preclinical research are fundamental steps of the drug discovery process. R&D pipelines are filled with a large number of new molecules and medical devices destined to treat patients and to improve their quality of life. Knowledge of drug or device activities is strategic to start building claims and to position the candidate in the large map of today’s drugs.

  • Bronchodilators
  • Corticosteroids
  • Mucolytics
  • Antibiotics
  • Correctors and potentiators
  • Gene therapy
  • Nitric oxide
  • Medical device

Some of these treatments fail in clinical trials debilitating resources, time and fracturing patients’ hopes.


Integrating Rheomuco in early clinical research

Rheomuco will offer additional information to the classical pharmacodynamics and pharmacokinetics data. If mucus rheology is used throughout the R&D process, it offers a better understanding of the disease characteristics as well as the therapeutic response including drug efficacy and clear analysis to support your decision-making on the next steps of your drug or device development.

The translational and preclinical studies have diverse purposes, mucus rheology can be used to fulfil the following objectives :

Sample volume have always been an obstacle to using mucus rheology for pre-clinical studies. With Rheomuco, you can testing samples starting 20µL! 

We are always open for a conversation about Rheomuco!

Contact us!